Starfish Innovations is an investment fund and commercialization hub that seeks to accelerate breakthroughs in regenerative medicine. Founded in 2016 by the Leiden University Medical Centre (LUMC), we have been able to build a strong early-stage pipeline of regenerative medicine technologies through our direct access to the promising science at LUMC as well as our global network of academic institutions and industry alike.
- LRMP provides resources and access to facilities to bring RM solutions closer to the patient.
- LRMP aims to lower barriers for commercial breakthrough of RM innovations.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Albinusdreef 2, Leiden,zuid-Holland 2333za,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Regenerative Medicine, Biotechnology, Cell Therapy, Gene Therapy, GMP Manufacturing, Organ-on-a-chip Technology, iPSC, Stem Cells, Private Funding, Grants, Commercialization, Investment, Venture Capital, Partnerships, Spin-off, Out-licensing.
- HQ
- Leiden, Zuid-Holland
Starfish Innovations Questions
Starfish Innovations's website is https://www.starfishinnovations.com/
Starfish Innovations's LinkedIn profile is https://nl.linkedin.com/company/lrmp
Starfish Innovations has
3 employees.
View email and phone details for 3
employees at Starfish Innovations.
Starfish Innovations's industry is
Biotechnology Research
Starfish Innovations's top competitors are
Plnt Leiden,
Skylinedx Bv,
Swanbridge Capital,
Giotto Management Consultants,
Luris,
Tieken.bio,
Rivm Gezond Leven,
Necstgen,
Stemx Bio,
Birds Biomedical.
Starfish Innovations's categories are Biotechnology Research
Starfish Innovations's founding year is 2016
